Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review
暂无分享,去创建一个
[1] J. R.,et al. Quantitative analysis , 1892, Nature.
[2] Michael,et al. Dopamine receptor sites in the anterior pituitary. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[3] D. Sibley,et al. Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. , 1982, The Journal of biological chemistry.
[4] M. Titeler,et al. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor. , 1982, European journal of pharmacology.
[5] S. Lazareno,et al. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. , 1982, European journal of pharmacology.
[6] C. Marsden,et al. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration. , 1983, Biochemical pharmacology.
[7] P. Jenner,et al. Differential anatomical location of [3H]‐N,n‐propylnorapomorphine and [3 H]‐spiperone binding sites in the striatum and substantia nigra of the rat , 1983, British journal of pharmacology.
[8] M. Dubocovich,et al. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. , 1983, The Journal of pharmacology and experimental therapeutics.
[9] H. Feldman. Statistical limits in Scatchard analysis. , 1983, The Journal of biological chemistry.
[10] D. Sibley,et al. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. , 1983, Molecular Pharmacology.
[11] I. Creese,et al. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. , 1984, Biochemical pharmacology.
[12] C. Altar,et al. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: Plasticity of neostriatal dopamine receptors after nigrostriatal injury , 1984, Brain Research.
[13] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[14] J. Korf,et al. In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication. , 1984, European journal of pharmacology.
[15] I. Creese,et al. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states. , 1985, Molecular pharmacology.
[16] D. Kendall,et al. Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation. , 1985, European journal of pharmacology.
[17] I. Creese,et al. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor. , 1985, Molecular pharmacology.
[18] I. Creese,et al. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum. , 1986, European journal of pharmacology.
[19] A. Friedhoff,et al. Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists. , 1986, European journal of pharmacology.
[20] J. Korf,et al. Tracer and maximal specific binding of tritiated spiperone or N-n-propylnorapomorphine to quantify dopamine receptors in rat brain regions in vivo. , 1986, Life sciences.
[21] G. Pearlson,et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.
[22] G. Wooten,et al. Dopamine denervation does not alter in vivo 3H‐spiperone binding in rat striatum: Implications for external imaging of dopamine receptors in Parkinson's disease , 1986, Annals of neurology.
[23] E. Richfield,et al. Properties of D2 dopamine receptor autoradiography: High percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections , 1986, Brain Research.
[24] M. Raichle,et al. In vitro or in vivo receptor binding: Where does the truth lie? , 1986, Annals of neurology.
[25] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[26] H. Hall,et al. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. , 2009, Acta pharmacologica et toxicologica.
[27] P. Molinoff,et al. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[28] J M Links,et al. 3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[29] Philip Seeman,et al. Human brain dopamine receptors in children and aging adults , 1987, Synapse.
[30] P. Seeman,et al. The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors. , 1987, Journal of pharmacological methods.
[31] O. Gredal,et al. In Situ Molecular Size of Agonist Dopamine D‐2 Binding Sites in Rat Striatum , 1987, Journal of neurochemistry.
[32] J. Bennett,et al. [3H]Spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis , 1987, Brain Research.
[33] E. Richfield,et al. Comparative distribution of dopamine D‐1 and D‐2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys , 1987, The Journal of comparative neurology.
[34] A. Horita,et al. Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the rhesus monkey (Macaca mulatta) , 1987, Neurobiology of Aging.
[35] H. Hall,et al. Effects of temperature on the in vitro binding of 3H-raclopride to rat striatal dopamine-D2 receptors. , 1988, Pharmacology & toxicology.
[36] M. Goldstein,et al. Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine. , 1988, European journal of pharmacology.
[37] M. Phelps,et al. In vivo [3H]Spiperone Binding: Evidence for Accumulation in Corpus Striatum by Agonist-Mediated Receptor Internalization , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] R. M. Beckstead,et al. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography , 1988, The Journal of comparative neurology.
[39] M. Terai,et al. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum. , 1989, European journal of pharmacology.
[40] M. Gnegy,et al. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site. , 1989, Molecular pharmacology.
[41] H. Rosengarten,et al. A full repetitive jaw movement response after 70% depletion of caudate D1 receptors , 1989, Pharmacology Biochemistry and Behavior.
[42] D. Sibley,et al. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland. , 1989, Endocrinology.
[43] C. Halldin,et al. Comparison of the In Vitro Receptor Binding Properties of N‐[3H]Methylspiperone and [3H]Raclopride to Rat and Human Brain Membranes , 1990, Journal of neurochemistry.
[44] S. Boyce,et al. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis) , 1990, Brain Research.
[45] T. Reader,et al. Effects of monovalent cations on neostriatal dopamine D2 receptors labeled with [3H]raclopride. , 1990, Biochemical pharmacology.
[46] A. Crossman,et al. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat , 1990, Brain Research.
[47] G. Biggio,et al. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists , 1990, Brain Research.
[48] Päivi Marjamäki,et al. Age-dependent decline in human brain dopamine D1 and D2 receptors , 1990, Brain Research.
[49] P. Molinoff,et al. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. , 1991, Brain research. Developmental brain research.
[50] Päivi Marjamäki,et al. A post-mortem study on striatal dopamine receptors in Parkinson's disease , 1991, Brain Research.
[51] D. Wong,et al. Effects of endogenous dopamine on kinetics of [3H]N‐methylspiperone and [3H]raclopride binding in the rat brain , 1991, Synapse.
[52] D. Grigoriadis,et al. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. , 1992, The Journal of pharmacology and experimental therapeutics.
[53] R. Mcquade,et al. Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primates , 1992, Pharmacology Biochemistry and Behavior.
[54] J. Glowinski,et al. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: Distribution, regulation and relationship to coupling , 1992, Neuroscience.
[55] P. Hedlund,et al. Chronic nicotine treatment decreases dopamine D2 agonist binding in the rat basal ganglia. , 1992, Neuroreport.
[56] M. Sambrook,et al. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism , 1993, Brain Research.
[57] U Ruotsalainen,et al. Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[58] D. Grigoriadis,et al. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. , 1993, The Journal of pharmacology and experimental therapeutics.
[59] P Seeman,et al. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO , 1994, Synapse.
[60] Christer Halldin,et al. Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.
[61] C. Marsden,et al. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat , 1994, Neuropharmacology.
[62] 寺井 道夫. Comparison of [[3]H]YM-09151-2 with [[3]H]spiperone and [[3]H]raclopride for dopamine D-2 receptor binding to rat striatum , 1994 .
[63] M. Knowles,et al. Expression and pharmacological characterization of the human D3 dopamine receptor. , 1994, The Journal of pharmacology and experimental therapeutics.
[64] L. Eriksson,et al. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone , 1995, Psychiatry Research: Neuroimaging.
[65] C. Halldin,et al. Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.
[66] Ulla Ruotsalainen,et al. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride , 1995, Journal of the Neurological Sciences.
[67] P. Bédard,et al. Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[68] P. Hedlund,et al. Effects of CGS 21680 in vivo on dopamine D2 agonist binding in the rat brain , 1995, Brain Research.
[69] K. Fuxe,et al. Cholecystokinin Octapeptide In Vitro and Ex Vivo Strongly Modulates Striatal Dopamine D2 Receptors in Rat Forebrain Sections , 1995, The European journal of neuroscience.
[70] P. Strange,et al. [3H]Nemonapride and [3H]Spiperone Label Equivalent Numbers of D2 and D3 Dopamine Receptors in a Range of Tissues and Under Different Conditions , 1995, Journal of neurochemistry.
[71] Lars Farde,et al. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907 , 1996, Psychopharmacology.
[72] E. Jerning,et al. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites. , 1996, European journal of pharmacology.
[73] Luciana Giardino,et al. Right-left asymmetry of D1- and D2-receptor density is lost in the basal ganglia of old rats , 1996, Brain Research.
[74] S. Houle,et al. In vivo binding of [11C]SKF 75670 and [11C]SKF 82957 in rat brain: two dopamine D-1 receptor agonist ligands. , 1996, Life sciences.
[75] K. Kameyama,et al. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells. , 1996, Molecular pharmacology.
[76] S. Nishiyama,et al. Effects of Binge Pattern Cocaine Administration on Dopamine D1 and D2 Receptors in the Rat Brain: AnIn Vivo Study Using Positron Emission Tomography , 1996, The Journal of Neuroscience.
[77] T. Reader,et al. Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation , 1997, Neurochemistry International.
[78] A. Westlind-Danielsson,et al. Dopamine D2 receptor upregulation in rat neostriatum following in vivo infusion of forskolin , 1997, Neuroreport.
[79] J. Tallman,et al. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. , 1997, The Journal of pharmacology and experimental therapeutics.
[80] S. Potkin,et al. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains , 1997, Brain Research.
[81] G. Pearlson,et al. Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[82] Christer Halldin,et al. Effect of reserpine‐induced depletion of synaptic dopamine on [11C]Raclopride binding to D2‐dopamine receptors in the monkey brain , 1997, Synapse.
[83] W C Eckelman,et al. Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[84] D. Copolov,et al. The Binding of Both [3H]Nemonapride and [3H]Raclopride Is Increased in Schizophrenia , 1997, Biological Psychiatry.
[85] P B Hoffer,et al. Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.
[86] M. Herrera-Marschitz,et al. Perinatal Asphyxia Induces Long-Term Changes in Dopamine D1, D2, and D3Receptor Binding in the Rat Brain , 1997, Experimental Neurology.
[87] I. Creese,et al. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. , 1997, The Journal of pharmacology and experimental therapeutics.
[88] M. Nader,et al. Effect of cocaine self‐administration on striatal dopamine D1 receptors in rhesus monkeys , 1998, Synapse.
[89] The effect of acute kainic acid treatment on dopamine D2 receptors in rat brain , 1998, Neuroscience Research.
[90] J. Sergeant,et al. Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD , 1998, Behavioural Brain Research.
[91] M. Bergström,et al. N-[11C]Methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic , 1998, Psychiatry Research: Neuroimaging.
[92] F. J. White,et al. Alterations in Dopamine Release But Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice , 1998, The Journal of Neuroscience.
[93] M. Nader,et al. Effect of cocaine self‐administration on dopamine D2 receptors in rhesus monkeys , 1998, Synapse.
[94] D. Hovda,et al. Differences in D2 dopamine receptor binding in the neostriatum between cats hemidecorticated neonatally or in adulthood. , 1998, Brain research. Developmental brain research.
[95] P. Seeman,et al. Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.
[96] Flügge,et al. 5HT1A‐Receptor Binding in the Brain of Cyclic and Ovariectomized Female Rats , 1999, Journal of neuroendocrinology.
[97] Christer Halldin,et al. A PET study of D1-like dopamine receptor ligand binding , 1999, Psychopharmacology.
[98] R. Mailman,et al. Developmental Regulation of the Dopamine D1 Receptor in Human Caudate and Putamen , 1999, Neuropsychopharmacology.
[99] J. Joyce,et al. Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons , 1999, Neuropsychopharmacology.
[100] A. Gee,et al. Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone , 1999, Journal of Neural Transmission.
[101] P. Bédard,et al. Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[102] V Kaasinen,et al. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[103] O. Paulson,et al. SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors , 2000, Synapse.
[104] R. Mailman,et al. Quantification of D1B (D5) receptors in dopamine D1A receptor‐deficient mice , 2001, Synapse.
[105] S. Kapur,et al. Amphetamine‐sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges , 2002, Synapse.
[106] S. Kapur,et al. Dopamine D2 receptors internalize in their low-affinity state , 2002, Neuroreport.
[107] J. Holden,et al. Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP‐treated monkeys: PET studies with [11C]raclopride , 2002, Synapse.
[108] Doris J. Doudet,et al. In Vivo Receptor Assay with Multiple Ligand Concentrations: An Equilibrium Approach , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[109] Albert Gjedde,et al. Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G Protein , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[110] M. Senda,et al. Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique , 2002, Synapse.
[111] G. Sedvall,et al. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. , 2002, The American journal of psychiatry.
[112] Doris J Doudet,et al. Sequential Versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]raclopride: Effect of Methamphetamine , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[113] P. Seeman,et al. Dopamine displaces [3H]domperidone from high‐affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography , 2003, Synapse.
[114] M. Beu,et al. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[115] E. Krause,et al. Galpha(s) is palmitoylated at the N-terminal glycine. , 2003, The EMBO journal.
[116] S. Kapur,et al. In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. , 2003, Molecular pharmacology.
[117] E. Krause,et al. Gαs is palmitoylated at the N‐terminal glycine , 2003 .
[118] P. Fletcher,et al. Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments. , 2003, European journal of pharmacology.
[119] M. Beu,et al. In Vivo Measurement of D 2 Receptor Density and Affinity for 18 F-( 3N-Methyl ) Benperidol in the Rat Striatum with a PET System for Small Laboratory Animals , 2003 .
[120] P. Seeman,et al. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2 , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.
[121] Albert Gjedde,et al. MDMA‐evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain , 2004, Synapse.
[122] D. Coward,et al. Binding of 3H-spiperone and 3H-(−)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.
[123] Svante B. Ross,et al. Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.
[124] Sylvain Houle,et al. Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET , 2004, Synapse.
[125] S. Heales,et al. Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice , 2004, Experimental Neurology.
[126] Jogeshwar Mukherjee,et al. Measuring the in Vivo Binding Parameters of [18F]-Fallypride in Monkeys Using a PET Multiple-Injection Protocol , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[127] D. Jackson,et al. Kinetic properties of the in vivo accumulation of 3H-(−)-N-n-propylnorapomorphine in mouse brain , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.
[128] Rudie Kortekaas,et al. In vivo Binding Behavior of Dopamine Receptor Agonist (+)−PD 128907 and Implications for the “Ceiling Effect” in Endogenous Competition Studies with [11C]Raclopride—a Positron Emission Tomography Study in Macaca mulatta , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[129] Mark Slifstein,et al. In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride , 2004, Synapse.
[130] Sylvain Houle,et al. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats , 2004, Biological Psychiatry.
[131] Mark Slifstein,et al. Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C]N-Propyl-norapomorphine and [11C]Raclopride in Baboons , 2005, Journal of Pharmacology and Experimental Therapeutics.
[132] J. Tiihonen,et al. Striatal dopamine D1 receptors in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography , 2005, Brain Research.
[133] Ulla Ruotsalainen,et al. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence , 1994, Psychopharmacology.
[134] P. Seeman,et al. L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum , 2005, Journal of Neural Transmission.
[135] N. Ginovart,et al. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2high and D3high receptors , 2005, Synapse.
[136] Sylvain Houle,et al. Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography , 2006, Journal of neurochemistry.
[137] L. Trudeau,et al. Expression of D2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function , 2006, Neuropharmacology.
[138] Sidse Arnfred,et al. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: Comparison with results in vivo , 2006, Synapse.
[139] W. McGuire. Perinatal asphyxia. , 2012, Clinical evidence.
[140] Christer Halldin,et al. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: A comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride , 2006, Synapse.
[141] J. Holden,et al. Sequential versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]Raclopride: 2: Effects of DAT Inhibitors , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[142] G. Muehllehner,et al. Positron emission tomography , 2006, Physics in medicine and biology.
[143] T. Sotnikova,et al. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. , 2006, CNS & neurological disorders drug targets.
[144] M. Laruelle,et al. [11C]NNC 112 Selectivity for Dopamine D1 and Serotonin 5-HT2A Receptors: A PET Study in Healthy Human Subjects , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[145] Shitij Kapur,et al. Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO , 2007, Synapse.
[146] L. Minuzzi,et al. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography. , 2007, European journal of pharmacology.
[147] Evan D Morris,et al. Positron Emission Tomography Displacement Sensitivity: Predicting Binding Potential Change for Positron Emission Tomography Tracers Based on Their Kinetic Characteristics , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[148] Mark Slifstein,et al. In Vivo DA D1 Receptor Selectivity of NNC 112 and SCH 23390 , 2007, Molecular Imaging and Biology.
[149] B. Dean,et al. Treatment with haloperidol and diazepam alters GABAA receptor density in the rat brain , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[150] Ariel Graff-Guerrero,et al. Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C]raclopride in healthy humans , 2008, Human brain mapping.
[151] P. Seeman,et al. Increase of dopamine D2High receptors in the striatum of rats sensitized to caffeine motor effects , 2008, Synapse.
[152] P. Seeman,et al. Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia , 2008, Synapse.
[153] Alan A. Wilson,et al. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo. , 2008, Nuclear medicine and biology.
[154] T. Robinson,et al. Cocaine self-administration produces a persistent increase in dopamine D2High receptors , 2008, European Neuropsychopharmacology.
[155] E. London,et al. Estimation of D2-like Receptor Occupancy by Dopamine in the Putamen of Hemiparkinsonian Monkeys , 2008, Neuropsychopharmacology.
[156] Flemming Andersen,et al. Evaluation of the Novel 5-HT4 Receptor PET Ligand [11C]SB207145 in the Göttingen Minipig , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[157] Jaanus Harro,et al. Rats with persistently high exploratory activity have both higher extracellular dopamine levels and higher proportion of D 2High receptors in the striatum , 2009, Synapse.
[158] D. Sibley,et al. Pharmacological characterization of 2‐methoxy‐N‐propylnorapomorphine's interactions with D2 and D3 dopamine receptors , 2009, Synapse.
[159] M. Nader,et al. Abstinence from Chronic Cocaine Self-Administration Alters Striatal Dopamine Systems in Rhesus Monkeys , 2009, Neuropsychopharmacology.
[160] Mark Slifstein,et al. In vivo quantification of regional dopamine‐D3 receptor binding potential of (+)‐PHNO: Studies in non‐human primates and transgenic mice , 2009, Synapse.
[161] Christer Halldin,et al. Dopamine D 2/3 Receptor Occupancy of Apomorphine in the Nonhuman Primate Brain—A Comparative PET Study With , 2022 .
[162] Jouke Dijkstra,et al. Changes in GABAA receptor properties in amygdala kindled animals: In vivo studies using [11C]flumazenil and positron emission tomography , 2009, Epilepsia.
[163] P. Seeman,et al. Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil , 2009, Synapse.
[164] Alan A. Wilson,et al. Ex vivo [11C]‐(+)‐PHNO binding is unchanged in animal models displaying increased high‐affinity states of the D2 receptor in vitro , 2009, Synapse.
[165] M. Millan. From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease. , 2010, Pharmacology & therapeutics.
[166] Mark Slifstein,et al. Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers , 2010, Neuropsychopharmacology.
[167] Claus Svarer,et al. Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET , 2010, NeuroImage.
[168] L. Mrzljak,et al. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]‐MNPA, [3H]‐(+)‐PHNO, and [3H]‐raclopride , 2010, Synapse.
[169] L. Minuzzi,et al. MDMA‐evoked changes in the binding of dopamine D2 receptor ligands in striatum of rats with unilateral serotonin depletion , 2010, Synapse.
[170] Alan A. Wilson,et al. Isoflurane Anaesthesia Differentially Affects the Amphetamine Sensitivity of Agonist and Antagonist D2/D3 Positron Emission Tomography Radiotracers: Implications for In Vivo Imaging of Dopamine Release , 2011, Molecular Imaging and Biology.
[171] L. Minuzzi,et al. Agonist binding fraction of dopamine D2/3 receptors in rat brain: A quantitative autoradiographic study , 2010, Neurochemistry International.
[172] Sylvain Houle,et al. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925. , 2010, The international journal of neuropsychopharmacology.
[173] F. Yasuno,et al. Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity. , 2010, Nuclear medicine and biology.
[174] E. Stein,et al. Effects of Early-Life Stress on Serotonin1A Receptors in Juvenile Rhesus Monkeys Measured by Positron Emission Tomography , 2010, Biological Psychiatry.
[175] Jeih-San Liow,et al. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse model , 2010, NeuroImage.
[176] J. Lieberman,et al. Characterization of in vivo Pharmacokinetic Properties of the Dopamine D1 Receptor Agonist DAR-0100A in Nonhuman Primates Using PET with [11C] NNC112 and [11C] Raclopride , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[177] Mark Jenkinson,et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.
[178] Striatal D 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence , .